Comparison of the Anti-Tumour Activity of the Somatostatin Receptor (SST) Antagonist [(177)Lu]Lu-Satoreotide Tetraxetan and the Agonist [(177)Lu]Lu-DOTA-TATE in Mice Bearing AR42J SST(2)-Positive Tumours

Limited experiments have compared the treatment effects of repetitive cycles of radiolabelled somatostatin (SST) analogues. In vitro and in vivo experiments were conducted in an AR42J cancer cell model, comparing the antagonist [(177)Lu]Lu-satoreotide tetraxetan with the agonist [(177)Lu]Lu-DOTA-TAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Plas, Pascale, Limana, Lorenzo, Carré, Denis, Thiongane, Amath, Raguin, Olivier, Mansi, Rosalba, Meyer-Losic, Florence, Lezmi, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506113/
https://www.ncbi.nlm.nih.gov/pubmed/36145306
http://dx.doi.org/10.3390/ph15091085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506113/
https://www.ncbi.nlm.nih.gov/pubmed/36145306
http://dx.doi.org/10.3390/ph15091085

Ejemplares similares